...
首页> 外文期刊>Human Molecular Genetics >The gene responsible for Dyggve-Melchior-Clausen syndrome encodes a novel peripheral membrane protein dynamically associated with the Golgi apparatus
【24h】

The gene responsible for Dyggve-Melchior-Clausen syndrome encodes a novel peripheral membrane protein dynamically associated with the Golgi apparatus

机译:负责Dyggve-Melchior-Clausen综合征的基因编码一种与高尔基体动态相关的新型外周膜蛋白

获取原文
获取原文并翻译 | 示例

摘要

Dyggve-Melchior-Clausen dysplasia (DMC) is a rare inherited dwarfism with severe mental retardation due to mutations in the DYM gene which encodes Dymeclin, a 669-amino acid protein of yet unknown function. Despite a high conservation across species and several predicted transmembrane domains, Dymeclin could not be ascribed to any family of proteins. Here we show, using in situ hybridization, that DYM is widely expressed in human embryos, especially in the cortex, the hippocampus and the cerebellum. Both the endogenous and the recombinant protein fused to green fluorescent protein co-localized with Golgi apparatus markers. Electron microscopy revealed that Dymeclin associates with the Golgi apparatus and with transitional vesicles of the reticulum–Golgi interface. Moreover, permeabilization assays revealed that Dymeclin is not a transmembrane but a peripheral protein of the Golgi apparatus as it can be completely released from the Golgi after permeabilization of the plasma membrane. Time lapse confocal microscopy experiments on living cells further showed that the protein shuttles between the cytosol and the Golgi apparatus in a highly dynamic manner and recognizes specifically a subset of mature Golgi membranes. Finally, we found that DYM mutations associated with DMC result in mis-localization and subsequent degradation of Dymeclin. These data indicate that DMC results from a loss-of-function of Dymeclin, a novel peripheral membrane protein which shuttles rapidly between the cytosol and mature Golgi membranes and point out a role of Dymeclin in cellular trafficking.
机译:Dyggve-Melchior-Clausen发育不良(DMC)是一种罕见的遗传性侏儒症,具有严重的智力发育迟缓,这是由于DYM基因突变引起的,该基因编码Dymeclin,一种功能未知的669个氨基酸的蛋白质。尽管跨物种的高度保守和几个预测的跨膜结构域,Dymeclin不能归因于任何蛋白质家族。在这里,我们使用原位杂交显示DYM在人类胚胎中广泛表达,尤其是在皮质,海马和小脑中。与绿色荧光蛋白融合的内源蛋白和重组蛋白均与高尔基体标记物共定位。电子显微镜显示,Dymeclin与高尔基体以及网状结构-高尔基体界面的过渡小泡有关。此外,通透性测定显示,Dymeclin不是高膜,而是高尔基体的外围蛋白,因为它在质膜通透后可以从高尔基体中完全释放出来。在活细胞上进行的延时共聚焦显微镜实验进一步表明,蛋白质以高度动态的方式在细胞质和高尔基体之间穿梭,并特异性识别成熟的高尔基体膜的一部分。最终,我们发现与DMC相关的DYM突变导致Dymeclin的定位错误和随后的降解。这些数据表明DMC是由Dymeclin的功能丧失导致的。Dymeclin是一种新型的外周膜蛋白,它在细胞溶质和成熟的高尔基膜之间快速穿梭,并指出了Dymeclin在细胞运输中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号